March 19, 2020 / 8:42 PM / 13 days ago

BRIEF-Armata Pharma Qtrly Loss Per Share $0.48

March 19 (Reuters) - Armata Pharmaceuticals Inc:

* ARMATA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS AND PROVIDES GENERAL CORPORATE UPDATE

* ARMATA PHARMACEUTICALS - AUDIT OPINION INCLUDED IN CO’S FORM 10-K FOR YEAR ENDED DEC. 31, 2019 CONTAINS GOING CONCERN EXPLANATORY PARAGRAPH

* ARMATA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.48 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below